ALFA Finder| Metric | H2 FY26 | H1 FY26 | H2 FY25 |
|---|---|---|---|
| Revenue from operations | 36.8 | 34.0 | 33.4 |
| Other income | 2.5 | 0.0 | 0.0 |
| Total income | 39.3 | 34.0 | 33.4 |
| Profit before exceptional items & tax | 8.1 | 2.0 | 2.6 |
| Profit before tax | 8.1 | 2.0 | 2.6 |
| Net profit | 3.4 | 0.7 | 2.0 |
| Operating margin | 20.6% | 5.9% | 7.8% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +70.00% |
|---|---|
| Net profit, quarter on quarter | +385.70% |
| Revenue, year on year | +10.20% |
NSE results filing, NSE: SUNREST. Figures extracted from the filing.
Sunrest Lifescience Ltd: key numbers
- Share price
- ₹36.00
- Market cap
- ₹30.90 Cr
- Revenue (annual)
- ₹70.83 Cr
- Net profit (annual)
- ₹4.12 Cr
- P/E (TTM)
- 7.5×Sector 43.8×
- Promoter holding
- 53.50%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sunrest Lifescience Ltd
All →Sunrest Lifescience Other Announcement
Sunrest Lifescience submitted a certificate confirming the non-applicability of corporate governance reporting requirements for the quarter ended 30th September 2026, due to its SME listing.
Sunrest Lifescience Board Meeting Outcome
Sunrest Lifescience Limited has cancelled its Rights Issue due to the non-receipt of the minimum subscription required by SEBI regulations.
Sunrest Lifescience Annual General Meeting
Sunrest Lifescience held its 9th AGM on 7 Sep 2026 via VC/OAVM. Resolutions covered adoption of FY26 financials, re-appointment of MD and WTD, and related-party transaction approval.
Sunrest Lifescience Capital Structure Change
Sunrest Lifescience Limited has extended its ongoing Rights Issue by nine days, with the new closing date set for September 11, 2026.
Sunrest Lifescience Business Update
Sunrest Lifescience Limited's subsidiary, Hetvi Lifesciences, is executing a ₹9.22 Crore order from Gujarat Medical Services Corporation Limited. ₹80.76 Lakhs worth of work is completed.
- Value
- ₹9.22 Cr
Sunrest Lifescience Annual General Meeting
Sunrest Lifescience Limited has issued a notice for its Annual General Meeting scheduled for September 7, 2026, to transact various ordinary and special businesses.
- Value
- ₹10.00 Cr